2 protocol(s) meet the specified criteria
PI: Tuchman, Sascha
Protocol No.TitleStatus
KCP-330-012STORMA Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-Dose Dexamethasone in Patients with Multiple Myeloma Previously Treated with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an anti-CD38 Monoclonal Antibody (mAb) and Refractory to Prior Treatment with Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor and an anti-CD38 mAbOpen
NP39403NP39403-Open label, Multicenter, Dose escalation/expansion phase 1b study to evaluate safety, pharmacokinetics and activity of BET inhibitor R06870810, given as mono and combination therapy to patients with advanced Multiple MyelomaOpen